期刊
FRONTIERS IN PHARMACOLOGY
卷 13, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2022.977741
关键词
KMT2A; MLL; ALL; AML; Leukemia; drug repositioining